Population growth is ‘not justified during the epidemic’, international scientists have said.
COVID-19 vaccine supplements are not necessary for the general public, a team of international scientists has said in a new report in a medical journal.
The report, published in The Lancet on Monday, confirms that despite the threat of Delta surveillance, “population growth is not yet justified.”
“Any decisions regarding the need for exacerbation or duration of the intervention should be based on a careful review of medical or clinical information, or both, indicating a continuous and beneficial reduction of risk factors for the disease,” scientists wrote.
Scientists say more evidence is needed to support the supplement, and that the vaccine remains effective in counteracting the high levels of COVID-19, in all major strains of the virus, including Delta.
Taken as a whole, the current studies do not provide reliable evidence of a very low level of protection against dangerous diseases, which is the main goal of the vaccine, “said WHO lead author Ana-Maria Henao-Restrepo.
He also said that the vaccine should be a priority for people around the world still waiting for the jab.
“If the vaccine is sent to the best of its ability, it can accelerate the eradication of the epidemic by preventing racial change,” he added.
This contradicts the US government’s decision to resume shooting more Americans vaccinated next week, subject to approval by health officials.
The authors agreed that some individuals, such as those who do not have adequate protection, may benefit from the additional measure.
A team of experts advising the U.S. Food and Drug Administration on vaccination is scheduled to meet on September 17 to discuss the increasing number of shootings of Pfizer-BioNTech, the first phase of the publication.
Lancet writers included WHO top scientists Soumya Swaminathan, Ana-Maria Henao-Restrepo and Mike Ryan.
Inadequacy of vaccination
Some countries have begun offering additional drugs due to fears over the range of Delta, prompting the WHO to call for a moratorium on third-party jabs in the event of a vaccination crisis in poor countries, where millions have not received their first jab.
The authors wrote: “The current vaccine can save many lives if used in people who have not previously been vaccinated.”
Countries like France are starting to distribute third-party seniors to the elderly and people with immune systems, while Israel has gone on, giving 12 or more children a third degree five months after receiving a second jab.
WHO Director-General Tedros Adhanom Ghebreyesus has called on countries to refrain from giving COVID extra jabs until the end of the year, with the UN health agency urging all countries to vaccinate at least 10% by the end of this month, and at least 40% by the end of this year.
The Lancet’s case confirms that the current changes have not been adequately designed to escape the immune system provided by the vaccine used here.
The authors suggest that if new viral mutations are found that could prevent this reaction, it is best to offer new vaccines that can be developed with new strains, rather than a third vaccine for an existing drug.